April 22, 2026

Ocular Surface Control: A Modern Approach to Peri-operative Dry Eye Management

Join us for a focused webinar exploring a modern approach to peri-operative dry eye management

The Ophthalmologist

March 02, 2026

FDA Okays Weekly Option in Achondroplasia

Navepegritide is described as the first therapy to deliver continuous C-type natriuretic peptide exposure over a weekly dosing interval in eligible pediatric patients.

Conexiant

March 02, 2026

Pediatricians at the Perioperative Helm

Pediatricians “uniquely positioned” to take active role in preanesthesia planning, says revised American Academy of Pediatrics report

Conexiant

March 02, 2026

Evolving Strategies in UCL Management: Repair vs. Reconstruction in the Modern Throwing Athlete

Ulnar collateral ligament (UCL) injury of the elbow — once considered career-ending for overhead athletes — is now a highly treatable condition with predictable return-to-play outcomes. Yet the surgical strategy is no longer one-size-fits-all.

Baptist Health South Florida

March 02, 2026

Shoulder MRI Findings May Not Explain Your Pain, New Research Suggests

If you’re over 40 and have shoulder pain, there’s a good chance an MRI scan would show what doctors call a “rotator cuff abnormality.” But new research suggests that finding alone may not explain why your shoulder hurts.

Baptist Health South Florida

February 26, 2026

Most Salivary Gland Neoplasms Found to Be Benign in Single-Center Study

Analysis of 50 cases shows moderate diagnostic agreement between FNAC and histopathology and identifies pleomorphic adenoma as the most common neoplasm.

Conexiant

February 26, 2026

‘You Aren’t Trapped’: Hundreds of US Nurses Choose Canada

Workforce shortages on both sides of the border add urgency.

KFF Health News

February 26, 2026

‘You Aren’t Trapped’: Hundreds of US Nurses Choose Canada

American healthcare workers are making a significant move to Canada, driven by political instability in the U.S. and the allure of a progressive health system.

Conexiant

February 25, 2026

FDA Approves First Therapy for Allergic Fungal Rhinosinusitis

Patients with allergic fungal rhinosinusitis now have a targeted biologic option.

Conexiant